Anke Stoefs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anke Stoefs has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Diana Isabela Costescu Strachinaru
Center for Infectious Diseases, Queen Astrid Military Hospital, 1120 Brussels, Belgium
2 shared publications - Marjan Van Esbroeck
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
2 shared publications - Patrick Soentjens
Centre for Infectious Diseases, Queen Astrid Military Hospital, 1120 Brussels, Belgium
2 shared publications - Peter Vanbrabant
Center for Infectious Diseases, Queen Astrid Military Hospital, 1120 Brussels, Belgium
2 shared publications - Pierre-Michel François
Medical Component Operational Command, Queen Astrid Military Hospital, 1120 Brussels, Belgium
2 shared publications - Alexia Verroken
Clinical Microbiology Department, Cliniques Universitaires Saint-Luc
1 shared publication
Latest Publications
- 8 November 2025
- Published by Elsevier in Acta Tropica
- Vol. 272, 107899
In search for tick-borne encephalitis virus and Rickettsia in Belgian Ixodes ricinus ticks: Evidence of rickettsia felis
- 8 November 2025
- Published by Elsevier in Acta Tropica
- Vol. 272, 107899
In search for tick-borne encephalitis virus and Rickettsia in Belgian Ixodes ricinus ticks: Evidence of rickettsia felis
- Open Access
- 8 May 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (5) , 128
Management and Prevention of Multidrug-Resistant Bacteria in War Casualties
The growing threat of antimicrobial resistance (AMR) is a critical issue for both civilians and the military. With each successive conflict, pathogens become more resistant, making the management of infections in casualties increasingly challenging. To better understand the scope and characteristics of conflict-related AMR, a comprehensive literature search was conducted in the PubMed database in April 2025, using defined search terms related to war casualties and antimicrobial resistance. We screened and included 117 relevant publications, comprising original research articles, reviews, case series, case reports, editorials, and commentaries, published in English or French, with no date restriction. This narrative review synthesizes current evidence on multidrug-resistant bacteria most commonly isolated from war casualties, their associated resistance mechanisms, and the microbiological diagnostic tools available at various levels of the military continuum of care (Roles 1–4). It also presents strategies for preventing cross-contamination and infection in resource-limited combat settings and provides practical, field-adapted recommendations for clinicians, from first responders to specialized care providers, aiming to improve infection management in armed conflict zones and mitigate the spread of AMR.
- 8 May 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (5) , 128
Open AccessManagement and Prevention of Multidrug-Resistant Bacteria in War Casualties
The growing threat of antimicrobial resistance (AMR) is a critical issue for both civilians and the military. With each successive conflict, pathogens become more resistant, making the management of infections in casualties increasingly challenging. To better understand the scope and characteristics of conflict-related AMR, a comprehensive literature search was conducted in the PubMed database in April 2025, using defined search terms related to war casualties and antimicrobial resistance. We screened and included 117 relevant publications, comprising original research articles, reviews, case series, case reports, editorials, and commentaries, published in English or French, with no date restriction. This narrative review synthesizes current evidence on multidrug-resistant bacteria most commonly isolated from war casualties, their associated resistance mechanisms, and the microbiological diagnostic tools available at various levels of the military continuum of care (Roles 1–4). It also presents strategies for preventing cross-contamination and infection in resource-limited combat settings and provides practical, field-adapted recommendations for clinicians, from first responders to specialized care providers, aiming to improve infection management in armed conflict zones and mitigate the spread of AMR.
- Open Access
- 19 September 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (9) , 221
Schistosomiasis in the Military—A Narrative Review
Schistosomiasis is a parasitosis caused by trematodes of the genus Schistosoma. Humans are infected when coming into contact with freshwater containing the parasites’ infective stages, which are amplified through freshwater-dwelling snails acting as intermediate hosts. Schistosomiasis has posed significant problems for troops exposed to freshwater in endemic regions ever since the Napoleonic wars. Schistosomiasis has substantial differences in clinical presentation, depending on the type of parasite, intensity of infection and reinfection, clinical form, and disease stage. It can remain undiagnosed for long periods of time, with well-known long-term morbidity and mortality risks. The diagnosis of schistosomiasis depends on its stage and relays on several tests, all with limitations in sensitivity and specificity. The diagnostic gold standard is the detection of eggs in urine, feces, or tissue biopsies, but this can raise problems in patients such as military personnel, in which the worm burden is usually low. Praziquantel is the drug of choice for schistosomiasis. Currently, there is no available commercial vaccine against any Schistosoma parasite. Avoiding freshwater exposure is the best prevention. Herein, we review the clinical presentation, diagnosis, treatment, and prevention of schistosomiasis in the military. This information may decrease the impact of schistosomiasis on this particular professional group.
- 19 September 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (9) , 221
Open AccessSchistosomiasis in the Military—A Narrative Review
Schistosomiasis is a parasitosis caused by trematodes of the genus Schistosoma. Humans are infected when coming into contact with freshwater containing the parasites’ infective stages, which are amplified through freshwater-dwelling snails acting as intermediate hosts. Schistosomiasis has posed significant problems for troops exposed to freshwater in endemic regions ever since the Napoleonic wars. Schistosomiasis has substantial differences in clinical presentation, depending on the type of parasite, intensity of infection and reinfection, clinical form, and disease stage. It can remain undiagnosed for long periods of time, with well-known long-term morbidity and mortality risks. The diagnosis of schistosomiasis depends on its stage and relays on several tests, all with limitations in sensitivity and specificity. The diagnostic gold standard is the detection of eggs in urine, feces, or tissue biopsies, but this can raise problems in patients such as military personnel, in which the worm burden is usually low. Praziquantel is the drug of choice for schistosomiasis. Currently, there is no available commercial vaccine against any Schistosoma parasite. Avoiding freshwater exposure is the best prevention. Herein, we review the clinical presentation, diagnosis, treatment, and prevention of schistosomiasis in the military. This information may decrease the impact of schistosomiasis on this particular professional group.